Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations
Read moreAn international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations
Read moreIt saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing
Read moreLiving kidney donation rates have remained stagnant over the last decade, and many potential living donors perceive the evaluation process
Read moreBy itself, beginning medical school is a major milestone. But the entering class of 2024 also experienced several significant firsts
Read moreA review of studies (meta-analysis) presented at this year’s ESCMID Conference on Coronavirus Diseases (ECCVID, online 23-25 September) shows that
Read moreTUESDAY, Sept. 22, 2020 — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is
Read moreAdding an immunotherapy agent to a three-drug chemotherapy regimen can improve the likelihood that early-stage triple-negative breast cancer will recede
Read moreA study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type
Read moreAt the epicentre of an explosion of new infections in Spain, the Madrid region was to unveil Friday a string
Read moreTikTok is pretty hit or miss when it comes to beauty hacks: The trendy heatless waves tutorial, for example—which uses
Read more